Metropolis Health receives notice for alleged anomalies in diagnostic tests

Metropolis has received a notice for alleged anomalies in diagnostic tests conducted in Delhi’s Aam Admi Mohalla clinics.

“Under Regulation 30 of the SEBI Listing Regulations, we wish to inform you that the company has, on May 10, 2024, at around 3.56 pm, received a notice from the Anti-Corruption Branch, New Delhi, in respect of registration of inquiry for alleged anomalies in diagnostics test conducted in Aam Aadmi Mohalla Clinic. There was a delay in disseminating the information within prescribed timelines as the company confirmed the facts, analyzed the notice, and determined its impact,” the company said in a filing to BSE and NSE.

The company clarified that the registration of the inquiry would not have any material financial impact on the company.

“As reported earlier, we have provided 100 percent of receivables due from the Aam Aadmi Mohalla Clinic from the start of the contract. (In Q424, the business received is only Rs 25 lakh and has been provided for),” the filing added.

The company said that it undertook all its operations as per contract and in compliance with applicable laws and will be fully cooperating with the authority in connection with the aforesaid inquiry and providing any information as asked for.

It is worth mentioning here that the CBI is investigating the allegations of “fake” lab tests and ghost patients in Aam Aadmi Mohalla Clinics.

It is alleged that some of the clinics allegedly ran lakhs of “fake” pathology and radiology tests on non-existent patients with irregularities worth hundreds of crores of rupees. “Fake and non-existent mobile numbers were used to register patients,” the office of the Delhi Lt Governor said.

For notice, click.
MB Bureau